 | Aldagen
Durham, NC
Aldagen’s proprietary products identify and isolate unique populations of adult stem cells with the potential to revolutionize treatments of cardiovascular disease and degenerative diseases. The Company is now testing these products in clinical trials. |
 | Biolex
Pittsboro, NC
Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. Biolex’ patented LEX SystemSM to produce therapeutic proteins to support its own development programs as well as the programs of its strategic partners. |
 | MaxCyte
Rockville, MD
MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of partnered
and internally developed therapeutic candidates. The Company’s proprietary ex vivo cell loading
technology overcomes critical obstacles, such as safety, scalability, and reproducibility, which are
fundamental to successful cell-based therapies. |
 | nContact, Inc.
Morrisville, NC
nContact is a medical device company that has designed and initiated development of a proprietary, minimally-invasive surgical platform to perform cardiac ablations.
|
